# TENET HEALTHCARE CORP (THC) FY2026 Q2 P&L / Income Statement

- Company: TENET HEALTHCARE CORP (THC)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-29, accession number 0000070318-26-000037
- Page: https://plicit.ai/financials/thc/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/thc-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Business Segment by Product and Service

Income statement for 2026-04-01 through 2026-06-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net operating revenues**: 5,628,000,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 4,127,000,000 US dollars
- **Operating income**: 1,501,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 161,000,000 US dollars
- **Income before income taxes**: 1,340,000,000 US dollars
- **Income tax expense**: 295,000,000 US dollars
- **Net income**: 1,045,000,000 US dollars
- **Hospital Operations**: 4,240,000,000 US dollars
- **Ambulatory Care - Revenue from other sources**: 70,000,000 US dollars
- **Ambulatory Care - Net patient service revenues**: 1,318,000,000 US dollars
- **Salaries, wages and benefits**: 2,231,000,000 US dollars
- **Supplies**: 984,000,000 US dollars
- **Other operating expenses, net**: 1,174,000,000 US dollars
- **Depreciation and amortization**: 215,000,000 US dollars
- **Impairment and restructuring charges, and acquisition-related costs**: 31,000,000 US dollars
- **Litigation and investigation costs**: 3,000,000 US dollars
- **Revenue from contract termination**: negative 413,000,000 US dollars
- **Equity in earnings of unconsolidated affiliates**: negative 65,000,000 US dollars
- **Net losses (gains) on sales, consolidation and deconsolidation of facilities**: negative 33,000,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to TENET HEALTHCARE CORP: $826.00 M; to noncontrolling interests: $219.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/thc/fy2026-q2-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/thc-fy2026-q2-revenue-by-business-segment-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net operating revenues**: 5,628,000,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 4,127,000,000 US dollars
- **Operating income**: 1,501,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 161,000,000 US dollars
- **Income before income taxes**: 1,340,000,000 US dollars
- **Income tax expense**: 295,000,000 US dollars
- **Net income**: 1,045,000,000 US dollars
- **Hospital Operations**: 4,240,000,000 US dollars
- **Ambulatory Care**: 1,388,000,000 US dollars
- **Salaries, wages and benefits**: 2,231,000,000 US dollars
- **Supplies**: 984,000,000 US dollars
- **Other operating expenses, net**: 1,174,000,000 US dollars
- **Depreciation and amortization**: 215,000,000 US dollars
- **Impairment and restructuring charges, and acquisition-related costs**: 31,000,000 US dollars
- **Litigation and investigation costs**: 3,000,000 US dollars
- **Revenue from contract termination**: negative 413,000,000 US dollars
- **Equity in earnings of unconsolidated affiliates**: negative 65,000,000 US dollars
- **Net losses (gains) on sales, consolidation and deconsolidation of facilities**: negative 33,000,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to TENET HEALTHCARE CORP: $826.00 M; to noncontrolling interests: $219.00 M.